NYSE:SOLVMedical Equipment
Will Activist Pressure and Reaffirmed EPS Guidance Reshape Solventum's (SOLV) Transformation Narrative?
Solventum Corporation recently reported first-quarter 2026 results showing revenue of US$2,007 million and net income of US$13 million, and held its Bank of America Global Healthcare Conference presentation on May 13, 2026, featuring senior leadership across investor relations and health information systems.
Alongside these results, analysts highlighted activist investor involvement and potential divestitures as important catalysts, while management maintained its full-year adjusted EPS...